share_log

Insitro Receives $25M In Milestone Payments From Bristol Myers Squibb For Achievement Of Discovery Milestones And Selection Of First Novel Genetic Target For ALS

Benzinga ·  Dec 18 22:02
Insitro Receives $25M In Milestone Payments From Bristol Myers Squibb For Achievement Of Discovery Milestones And Selection Of First Novel Genetic Target For ALS
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment